Austria's medicines and medical devices authority. It authorises national medicines and clinical trials, monitors side effects and inspects manufacturers, with staff provided by the AGES medicines market surveillance division.
The Bundesamt für Sicherheit im Gesundheitswesen began work on 2 January 2006, after the tasks were moved out of the health ministry, together with the medicines market surveillance division of the Austrian Agency for Health and Food Safety (AGES MEA, called AGES PharmMed until 1 January 2012), as the national authority for medicines, medical devices, blood and tissues. Its own description says it is responsible for which medicines are newly authorised in Austria, for authorising clinical trials of medicines and medical devices, for pharmacovigilance and device vigilance and for inspections, and that it monitors medicines on the market nationally and with its European sister agencies.
The BASG is an authority under the health ministry with three members appointed by the minister: one from the ministry, one from AGES, and the head of the AGES medicines market surveillance division; AGES provides its services, staff and buildings, and AGES MEA staff act on the BASG's behalf. Its legal basis is the Health and Food Safety Act. Cancer medicines authorised through the EU centralised procedure on the European Medicines Agency's opinion are valid in Austria without a national authorisation.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/